Fig. 3From: Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysisICRP biokinetic model for thorium. Details and parameter values are provided in reference [14]Back to article page